Survey on long-term use of avacopan for certain autoimmune diseases
Special Drug Use-results Survey for Long-term Use
This study looks at how well and safely avacopan works for Japanese patients with certain autoimmune diseases over a long time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Sex | All |
| Sponsor | Kissei Pharmaceutical Co., Ltd. Industry-sponsored |
| Locations | 1 site (Multiple Locations) |
| Trial ID | NCT06758271 on ClinicalTrials.gov |
What this trial studies
This survey evaluates the safety and efficacy of avacopan, a medication used for treating microscopic polyangiitis and granulomatosis with polyangiitis, in Japanese patients over a long-term period. The study is observational, meaning it will collect data on patients currently receiving avacopan under real-world conditions rather than in a controlled experimental setting. By monitoring patient outcomes and side effects, the survey aims to provide insights into the drug's effectiveness and safety profile in everyday clinical practice.
Who should consider this trial
Good fit: Ideal candidates for this survey are Japanese patients diagnosed with granulomatosis with polyangiitis or microscopic polyangiitis who are currently being treated with avacopan.
Not a fit: Patients who are not receiving avacopan or those with other unrelated conditions may not benefit from this survey.
Why it matters
Potential benefit: If successful, this survey could provide valuable information on the long-term safety and efficacy of avacopan, potentially improving treatment strategies for patients with these autoimmune diseases.
How similar studies have performed: While this survey focuses on long-term use in a specific population, similar studies evaluating the safety and efficacy of treatments for autoimmune diseases have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Where this trial is running
Multiple Locations
- Research site — Multiple Locations, Japan (Recruiting)
Study contacts
- Study coordinator: Kazunori Abe, director
- Email: rinsyousiken@pharm.kissei.co.jp
- Phone: 0356843575
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.